Trotana Therapeutics is a biotech company that focuses on the discovery and development of medicines targeting RNA-binding proteins.
Trotana Therapeutics has raised $52.5M in total funding. The most recent round was Series A. The last funding was announced in February 2025.
Trotana Therapeutics's investors include Lightstone Ventures.
Trotana Therapeutics is headquartered in San Diego, United States.
Trotana Therapeutics is a biotech company that focuses on the discovery and development of medicines targeting RNA-binding proteins.
Trotana Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Trotana Therapeutics — Funding & Investors." VCBacked, February 1, 2025, https://www.vcbacked.co/company/trotana-therapeutics. Accessed August 14, 2026.
VCBacked. (2025). Trotana Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/trotana-therapeutics
{{cite web |title=Trotana Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/trotana-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated